Kumar Neil
Director, Officer at BBIO
- Sold, on record
- $154M
- Dollars the filings state
- Form 4 sales
- 53
- Latest Nov 19, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BBIOBridgeBio Pharma, Inc.Director, Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BBIORoutineMay 8 2026
Sold 80,000 shares at $67.40 ($5.4M)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 1.8% of holdings ($299M position)4.4M shares left1x usual sizeFiling
- 2 Form 4 sale BBIORoutineMay 21 +13 days
Sold 26,103 shares at $69.44 ($1.8M)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 9.7% of holdings ($18.7M position)243,327 shares left0.3x usual sizeFiling
- 3 Form 4 sale BBIORoutineJun 5 +15 days
Sold 80,000 shares at $67.67 ($5.4M)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 1.8% of holdings ($298M position)4.3M shares left1x usual sizeFiling
- 4 Form 4 sale BBIORoutineAug 19 +75 days
Sold 44,980 shares at $82.86 ($3.7M)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 15.6% of holdings ($23.9M position)243,327 shares left0.6x usual sizeFiling
- 5 Form 4 sale BBIORoutineSep 17 +29 days
Sold 10,000 shares at $69.08 ($691k)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 2% of holdings ($34.9M position)495,686 shares left0.1x usual sizeFiling
- 6 Form 144 notice BBIONoticeNov 18 +62 days
Filed to sell 34,980 shares ($2.7M)
Kumar Neil, Director, Officer
10b5-1 plan0.4x usual sizeFiling
- 7 Form 144 notice BBIONoticeNov 19 +1 day
Filed to sell 30,000 shares ($2.3M)
Kumar Neil, Director, Officer
10b5-1 plan0.4x usual sizeFiling
- 8 Form 4 sale BBIORoutineNov 19 same day
Sold 54,980 shares at $77.86 ($4.3M)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 18.4% of holdings ($23.2M position)243,327 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (60)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 54,980 | $4.3M | 18.4% | Routine | SEC |
| Nov 19, 2026 | BBIO | Director, Officer | Form 144 notice | 30,000 | $2.3M | Notice | SEC | |
| Nov 18, 2026 | BBIO | Director, Officer | Form 144 notice | 34,980 | $2.7M | Notice | SEC | |
| Sep 17, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 10,000 | $691k | 2.0% | Routine | SEC |
| Aug 19, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 44,980 | $3.7M | 15.6% | Routine | SEC |
| Jun 5, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $5.4M | 1.8% | Routine | SEC |
| May 21, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 26,103 | $1.8M | 9.7% | Routine | SEC |
| May 8, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $5.4M | 1.8% | Routine | SEC |
| Apr 10, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $6M | 1.8% | Routine | SEC |
| Mar 13, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $5.5M | 1.8% | Routine | SEC |
| Feb 19, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 28,053 | $2M | 10.7% | Routine | SEC |
| Feb 11, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $5.7M | 1.8% | Routine | SEC |
| Jan 9, 2026 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $6M | 1.7% | Routine | SEC |
| Dec 15, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 30,011 | $2.2M | 11.6% | Routine | SEC |
| Dec 5, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $5.9M | 1.7% | Routine | SEC |
| Nov 20, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 26,156 | $1.7M | 10.3% | Routine | SEC |
| Nov 7, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $5M | 9.1% | Routine | SEC |
| Oct 9, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $4.4M | 8.7% | Routine | SEC |
| Sep 5, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $4.2M | 8.4% | Routine | SEC |
| Aug 20, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 26,156 | $1.3M | 10.5% | Routine | SEC |
| Aug 8, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $3.7M | 8.0% | Routine | SEC |
| Jul 2, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 80,000 | $3.4M | 7.7% | Routine | SEC |
| May 20, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 101,156 | $3.4M | 31.8% | Routine | SEC |
| Apr 22, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 75,000 | $2.6M | 1.5% | Routine | SEC |
| Mar 25, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 75,000 | $2.8M | 1.5% | Routine | SEC |
| Feb 25, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 75,000 | $2.5M | 1.5% | Routine | SEC |
| Feb 19, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 31,543 | $1.1M | 13.0% | Routine | SEC |
| Jan 29, 2025 | BBIO | Chief Executive Officer | Form 4 sale | 600,000 | $21.8M | 10.5% | Unusual | SEC |
| Nov 19, 2024 | BBIO | Chief Executive Officer | Form 4 sale | 27,389 | $614k | 0.6% | Routine | SEC |
| Aug 19, 2024 | BBIO | Chief Executive Officer | Form 4 sale | 27,389 | $676k | 0.6% | Routine | SEC |
| Nov 17, 2023 | BBIO | CEO and President | Form 4 sale | 51,552 | $1.5M | 1.1% | Routine | SEC |
| Nov 17, 2023 | BBIO | Officer | Form 144 notice | 51,552 | $1.5M | Notice | SEC | |
| Aug 17, 2023 | BBIO | CEO and President | Form 4 sale | 51,552 | $1.5M | 1.1% | Routine | SEC |
| Aug 17, 2023 | BBIO | Director, Officer | Form 144 notice | 51,552 | $1.5M | Notice | SEC | |
| May 17, 2023 | BBIO | CEO and President | Form 4 sale | 51,552 | $722k | 1.1% | Routine | SEC |
| May 17, 2023 | BBIO | Officer | Form 144 notice | 51,552 | $726k | Notice | SEC | |
| May 3, 2023 | BBIO | CEO and President | Form 4 sale | 120,000 | $1.7M | 10.6% | Routine | SEC |
| May 3, 2023 | BBIO | Officer | Form 144 notice | 120,000 | $1.7M | Notice | SEC | |
| Apr 5, 2023 | BBIO | CEO and President | Form 4 sale | 120,000 | $1.9M | 9.6% | Routine | SEC |
| Apr 5, 2023 | BBIO | Officer | Form 144 notice | 120,000 | $1.9M | Notice | SEC | |
| Mar 3, 2023 | BBIO | CEO and President | Form 4 sale | 120,000 | $1.3M | 8.7% | Plan not stated | SEC |
| Feb 17, 2023 | BBIO | CEO and President | Form 4 sale | 44,798 | $569k | 0.9% | Plan not stated | SEC |
| Feb 3, 2023 | BBIO | CEO and President | Form 4 sale | 120,000 | $1.3M | 8.0% | Plan not stated | SEC |
| Jan 5, 2023 | BBIO | CEO and President | Form 4 sale | 120,000 | $920k | 7.4% | Plan not stated | SEC |
| Dec 21, 2022 | BBIO | CEO and President | Form 4 sale | 200,000 | 16.7% | Plan not stated | SEC | |
| Nov 17, 2022 | BBIO | CEO and President | Form 4 sale | 34,640 | $326k | 0.7% | Plan not stated | SEC |
| Aug 4, 2020 | BBIO | CEO and President | Form 4 sale | 80,000 | $2.2M | 3.7% | Plan not stated | SEC |
| Jul 2, 2020 | BBIO | CEO and President | Form 4 sale | 143,470 | $4.4M | 6.2% | Plan not stated | SEC |
| Jun 8, 2020 | BBIO | CEO and President | Form 4 sale | 10,600 | $318k | 0.5% | Plan not stated | SEC |
| Jun 3, 2020 | BBIO | CEO and President | Form 4 sale | 5,930 | $178k | 0.3% | Plan not stated | SEC |
| Jun 1, 2020 | BBIO | CEO and President | Form 4 sale | 80,000 | $2.3M | 3.3% | Plan not stated | SEC |
| May 5, 2020 | BBIO | CEO and President | Form 4 sale | 79,600 | $2.5M | 3.2% | Plan not stated | SEC |
| May 4, 2020 | BBIO | CEO and President | Form 4 sale | 80,400 | $2.4M | 3.1% | Plan not stated | SEC |
| Apr 7, 2020 | BBIO | CEO and President | Form 4 sale | 1,805 | $46k | 0.1% | Plan not stated | SEC |
| Apr 3, 2020 | BBIO | CEO and President | Form 4 sale | 300 | $8k | 0.0% | Plan not stated | SEC |
| Apr 2, 2020 | BBIO | CEO and President | Form 4 sale | 77,895 | $2M | 2.9% | Plan not stated | SEC |
| Mar 3, 2020 | BBIO | CEO and President | Form 4 sale | 120,000 | $3.9M | 4.3% | Plan not stated | SEC |
| Feb 5, 2020 | BBIO | CEO and President | Form 4 sale | 30,893 | $1.1M | 1.1% | Plan not stated | SEC |
| Feb 4, 2020 | BBIO | Officer, Director | Form 4 sale | 89,107 | $3.1M | 3.1% | Plan not stated | SEC |
| Jan 3, 2020 | BBIO | Officer, Director | Form 4 sale | 120,000 | $3.9M | 4.0% | Plan not stated | SEC |